Santhera Pharmaceuticals Holding Performance

Santhera Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  1,228  in Santhera Pharmaceuticals Holding on November 12, 2025 and sell it today you would earn a total of  107.00  from holding Santhera Pharmaceuticals Holding or generate 8.71% return on investment over 90 days. Santhera Pharmaceuticals Holding is currently producing 0.198% returns and takes up 1.3136% volatility of returns over 90 trading days. Put another way, 11% of traded pink sheets are less volatile than Santhera, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.Assuming the 90 days horizon Santhera Pharmaceuticals is expected to generate 1.62 times more return on investment than the market. However, the company is 1.62 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Santhera Pharmaceuticals Target Price Odds to finish over Current Price

Assuming the 90 days horizon Santhera Pharmaceuticals Holding has a beta of -0.11. This usually implies as returns on the benchmark increase, returns on holding Santhera Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Santhera Pharmaceuticals Holding is likely to outperform the market. Additionally Santhera Pharmaceuticals Holding has an alpha of 0.0134, implying that it can generate a 0.0134 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Santhera Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Santhera Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 12.04 13.35 14.66 Details

Intrinsic Valuation Low Real High 9.81 11.12 14.69 Details

Santhera Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Santhera Pharmaceuticals is not an exception. The market had few large corrections towards the Santhera Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Santhera Pharmaceuticals Holding, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Santhera Pharmaceuticals within the framework of very fundamental risk indicators.

Santhera Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Santhera Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Santhera Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Santhera Pharmaceuticals Fundamentals Growth

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

If you are still planning to invest in Santhera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Santhera Pharmaceuticals' history and understand the potential risks before investing.